Linda ChamberlainEndowed Chair for Entrepreneurship & Innovation at GVSU and Principal at InnoValuation
Linda Chamberlain has led strategic business and product development at Fortune 200, mid-sized and start-up companies for more than 25 years, including Shell Chemical, Honeywell, and Johnson Controls. Currently she is Director with the Michigan Accelerator Fund, a venture capital fund serving Michigan-based life science companies, and CEO of NanoRETE, a start-up delivering new diagnostic technology for tuberculosis. Prior to this, she led global strategy and product commercialization for Global Forex Trading, which was acquired in 2012 for $108M. Linda, as Executive Director, led the West Michigan Science and Technology Initiative, a business accelerator focused on commercialization of life science products and technologies, and as Executive Director for the Center for Entrepreneurship and Innovation at Grand Valley State University. She is also the owner and principal of InnoValuation®, a company that focuses on insuring companies have the processes and performance to extract the full value from their innovations.
Dr. Chamberlain received both her BS and PhD in Chemistry from Purdue University, and has 19 patents issued for catalyst, polymer, and product/process development. Dr. Chamberlain has served or is serving on the boards of Tissue Regeneration Systems, AuthentiApp, and Frederik Meijer Gardens.